XyloCor Therapeutics

0 followers


XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Industries

Employees

11-50

Links

Org chart

Albert Gianchetti
Chief Executive Officer

Albert Gianchetti

Collapse
Howard Dittrich
Chief Medical Officer
Alexander Gaidamaka
SVP of Technology, Manufacturing & Quality
Dawn Byrnes
VP, Clinical Operations